amiodarone has been researched along with ANS (Autonomic Nervous System) Diseases in 3 studies
Amiodarone: An antianginal and class III antiarrhythmic drug. It increases the duration of ventricular and atrial muscle action by inhibiting POTASSIUM CHANNELS and VOLTAGE-GATED SODIUM CHANNELS. There is a resulting decrease in heart rate and in vascular resistance.
amiodarone : A member of the class of 1-benzofurans that is 1-benzofuran substituted by a butyl group at position 2 and a 4-[2-(diethylamino)ethoxy]-3,5-diiodobenzoyl group at position 3. It is a cardiovascular drug used for the treatment of cardiac dysrhythmias.
| Excerpt | Relevance | Reference |
|---|---|---|
| " The effects of amiodarone on circadian variation of these variables were determined in rats with myocardial infarction and subsequent congestive heart failure (CHF)." | 7.77 | Circadian changes in autonomic function in conscious rats with heart failure: effects of amiodarone on sympathetic surge. ( Asanoi, H; Hirai, T; Inoue, H; Joho, S; Kameyama, T; Nozawa, T; Ohori, T, 2011) |
| "Atypical manifestations of pulmonary toxicity and previously unreported autonomic nervous system dysfunction complicating amiodarone therapy were observed in a patient being treated for sustained ventricular tachycardia." | 4.77 | Atypical pulmonary and neurologic complications of amiodarone in the same patient. Report of a case and review of the literature. ( Estes, NA; Mack, KD; Manolis, AS; Tordjman, T, 1987) |
| " The effects of amiodarone on circadian variation of these variables were determined in rats with myocardial infarction and subsequent congestive heart failure (CHF)." | 3.77 | Circadian changes in autonomic function in conscious rats with heart failure: effects of amiodarone on sympathetic surge. ( Asanoi, H; Hirai, T; Inoue, H; Joho, S; Kameyama, T; Nozawa, T; Ohori, T, 2011) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (33.33) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 2 (66.67) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Ramos-Rúa, L | 1 |
| Álvarez-Fernández, L | 1 |
| Nogueira-Fernández, V | 1 |
| da Silva-Franca, CF | 1 |
| Brañas-Fernández, FM | 1 |
| Pego-Reigosa, R | 1 |
| Cortés-Laíño, JA | 1 |
| Ohori, T | 1 |
| Hirai, T | 1 |
| Joho, S | 1 |
| Kameyama, T | 1 |
| Nozawa, T | 1 |
| Asanoi, H | 1 |
| Inoue, H | 1 |
| Manolis, AS | 1 |
| Tordjman, T | 1 |
| Mack, KD | 1 |
| Estes, NA | 1 |
2 reviews available for amiodarone and ANS (Autonomic Nervous System) Diseases
| Article | Year |
|---|---|
[Paroxysmal atrial fibrillation within the context of cluster headaches].
Topics: Amiodarone; Anti-Inflammatory Agents, Non-Steroidal; Atrial Fibrillation; Autonomic Nervous System D | 2015 |
Atypical pulmonary and neurologic complications of amiodarone in the same patient. Report of a case and review of the literature.
Topics: Aged; Amiodarone; Autonomic Nervous System Diseases; Diagnosis, Differential; Female; Humans; Hypote | 1987 |
1 other study available for amiodarone and ANS (Autonomic Nervous System) Diseases
| Article | Year |
|---|---|
Circadian changes in autonomic function in conscious rats with heart failure: effects of amiodarone on sympathetic surge.
Topics: Amiodarone; Animals; Anti-Arrhythmia Agents; Autonomic Nervous System Diseases; Chronobiology Disord | 2011 |